ID

31306

Description

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Any adverse experience is defined as a new or worsening pre-existing medical condition or complication occurring while on study, regardless of its perceived relationship to the drug. Please record all adverse experiences from the time of study entry through the Week 13 visit.

Keywords

Versions (1)
  1. 8/12/18 8/12/18 -
Copyright Holder

see clinicaltrials.gov

Uploaded on

August 12, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

English

Adverse Experiences

1 forms  
  1. StudyEvent: ODM
    1. Adverse Experiences
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Site Number
Description

Site number

Data type

text

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Description

Patient Initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Adverse Experiences
Description

Adverse Experiences

Alias
UMLS CUI-1
C0877248
AE #
Description

Adverse Event; Number

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0237753
Adverse Experience (one experience per line)
Description

Adverse Event

Data type

text

Alias
UMLS CUI [1]
C0877248
Grade per CTC (per Appx F)
Description

Adverse Event; CTC grade

Data type

text

Alias
UMLS CUI [1]
C2985911
Serious
Description

Adverse event, serious

Data type

boolean

Alias
UMLS CUI [1]
C1519255
Onset Date
Description

Adverse event; start date

Data type

date

Alias
UMLS CUI [1]
C2697888
Stop Date
Description

Adverse event; end date

Data type

date

Alias
UMLS CUI [1]
C2697886
Frequency
Description

Adverse event; frequency

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439603
Therapeutic Measures: Drugs
Description

Adverse event; Therapeutic Measures; Drugs

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0013227
Therapeutic Measures: Other
Description

Adverse event; Therapeutic Measures; Other

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
Therapeutic Measures: If Other, specify here
Description

Adverse event; Therapeutic Measures; Other; Specification

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C2348235
Outcome
Description

Adverse event; Outcome

Data type

text

Alias
UMLS CUI [1]
C1705586
Relationship: Drug
Description

Adverse event; Relationship; Drug

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0013227
Relationship: Disease
Description

Adverse event; Relationship; Disease

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0012634
Back to the top of the page

Similar models

Adverse Experiences

1 forms
  1. StudyEvent: ODM
    1. Adverse Experiences
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Site number
Item
Site Number
text
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Adverse Experiences
C0877248 (UMLS CUI-1)
Adverse Event; Number
Item
AE #
integer
C0877248 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Adverse Event
Item
Adverse Experience (one experience per line)
text
C0877248 (UMLS CUI [1])
Adverse Event; CTC grade
Item
Grade per CTC (per Appx F)
text
C2985911 (UMLS CUI [1])
Adverse event, serious
Item
Serious
boolean
C1519255 (UMLS CUI [1])
Adverse event; start date
Item
Onset Date
date
C2697888 (UMLS CUI [1])
Adverse event; end date
Item
Stop Date
date
C2697886 (UMLS CUI [1])
Adverse event; frequency
Item
Frequency
text
C0877248 (UMLS CUI [1,1])
C0439603 (UMLS CUI [1,2])
Adverse event; Therapeutic Measures; Drugs
Item
Therapeutic Measures: Drugs
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Adverse event; Therapeutic Measures; Other
Item
Therapeutic Measures: Other
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Adverse event; Therapeutic Measures; Other; Specification
Item
Therapeutic Measures: If Other, specify here
text
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Adverse event; Outcome
Item
Outcome
text
C1705586 (UMLS CUI [1])
Adverse event; Relationship; Drug
Item
Relationship: Drug
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Adverse event; Relationship; Disease
Item
Relationship: Disease
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial